So the really deadly part of the virus is the body's inflammatory response. Do we know yet if people who usually suffer from inflammatory responses/conditions (insect bites, eczema, asthma, arthritis, gum disease) are more likely to be badly affected? Does it work like that?
Given its a cheap drug as well the potential for use around the world is huge albeit it in a hospital setting.
I don't wish to appear cynical here but surely the fact that there is some positive news to announce and BoZo decided to do todays briefing himself is pure co-incidence.
Good news about dexamethasone.
https://www.bbc.co.uk/news/live/world-53059487 "the drug dexamethasone which could save the life of one in eight patients who experience serious breathing problems is widely available and cheap."
Yes, I did read the thread but I had just constructed a large post about dexamethasone and remdesivir and in the end decided to abandon it but I couldn't bring myself to delete all of it so I left in the bit about 1 in 8 ..Do you read this thread?
Oh I used to have those eye drops.If people want to have a look at what it's used for now....
Dexamethasone | Drugs | BNF content published by NICE
View dexamethasone information, including dose, uses, side-effects, renal impairment, pregnancy, breast feeding, contra-indications and monitoring requirements.bnf.nice.org.uk
LynnDoyleCooper can we take it Convalescent plasma didn't have a positive effect, or does the trial continue?
No don't worry I might check it out tomorrow.No idea, I'll have a look about.
No don't worry I might check it out tomorrow.
The plasma trial was in the same UK NHS trial as the dexamethasone.
LynnDoyleCooper can we take it Convalescent plasma didn't have a positive effect, or does the trial continue?
Dr Varon admits he's "thrown the kitchen sink" at trying to find new ways of beating this virus.
And now he thinks there's a game-changer.
He and a group of medical colleagues from five different hospitals across America have created a cocktail of commonly but separately-used drugs they're calling the Math+ protocol - and the combination is having some staggering results.
Math+ includes cortisone steroid, vitamins and anti-coagulants to try to curb the key challenges caused by the virus - blood clotting and inflammation.
"We've been doing it for a few months now,' Dr Varon said, and "it's working a charm".
He very much believes the hospital's 100% success rate for nearly three months is down to Math+.
The Houston Memorial Medical Centre seems to think they have found the answer, having a 100% success rate over 3 months, recently dropped to 96%, which is still bloody impressive. Worth reading the full article.
Coronavirus: Houston doctor says 'we're heading to pure hell' as COVID-19 cases spike in Texas
A doctor tells Sky News they are receiving many more sick patients and are bracing themselves for a "tsunami" of infections.news.sky.com
The preliminary results of a clinical trial suggest a new treatment for Covid-19 dramatically reduces the number of patients needing intensive care, according to the UK company that developed it.
The treatment from Southampton-based biotech Synairgen uses a protein called interferon beta which the body produces when it gets a viral infection.
The protein is inhaled directly into the lungs of patients with coronavirus, using a nebuliser, in the hope that it will stimulate an immune response.
The initial findings suggest the treatment cut the odds of a Covid-19 patient in hospital developing severe disease - such as requiring ventilation - by 79%.
Patients were two to three times more likely to recover to the point where everyday activities were not compromised by their illness, Synairgen claims.
It said the trial also indicated "very significant" reductions in breathlessness among patients who received the treatment.
In addition, the average time patients spent in hospital is said to have been reduced by a third, for those receiving the new drug - down from an average of nine days to six days.
Here's a possible treatment for those admitted to hospital, although it's early days, the double-blind trial only involved 101 patients, and the research hasn't been peer-reviewed yet, but it sounds promising.
Coronavirus: Protein treatment trial 'a breakthrough'
Synairgen says preliminary results suggest its nebuliser treatment can lower the risk of disease.www.bbc.co.uk
Here's a possible treatment for those admitted to hospital, although it's early days, the double-blind trial only involved 101 patients, and the research hasn't been peer-reviewed yet, but it sounds promising.
Coronavirus: Protein treatment trial 'a breakthrough'
Synairgen says preliminary results suggest its nebuliser treatment can lower the risk of disease.www.bbc.co.uk
I wonder why 100 million?
I also wonder how long Oxford Uni will want their name attached to it? Its all good publicity now but at some point they'll need to give it a medical name especially when they find out that in 1% it causes a tail to grow from your forehead.
Maybe if it doesn't give long term immunity, which they won't know yet, it could be we have a yearly vaccine (like a flu jab scenario). So makes sense to stock up . However if the govt have actually managed to order something that works and arrives is another thing.I wonder why 100 million?
I also wonder how long Oxford Uni will want their name attached to it? Its all good publicity now but at some point they'll need to give it a medical name especially when they find out that in 1% it causes a tail to grow from your forehead.